house · trading 2022-08-26 → 2025-07-28
*Purchases reported over roughly the last three years, weighted by the midpoint of each disclosed dollar band and marked to the latest close. Filings state a range, never a share count, so this tracks the stock rather than the position. It is not a dollar figure and it is not what this member made.
▮ buys · ▮ sells
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2025-07-28 | GSK | SELL | $1K–$15K | $37.45 | $51.10 2026-10-26 | -36.5% exit |
| 2022-12-05 | TSLA | SELL | $1K–$15K | $182.45 | $354.08 2026-09-04 | -94.1% exit |
| 2022-08-26 | AAPL | BUY | $1K–$15K | $163.62 | $319.97 2026-09-04 | +95.6% |
Buys are marked to the latest close and treated as still open. A sell tagged rt closes an earlier disclosed buy in the same name. exit reads from the seller's side: how the stock moved after they were out.
| Member | Shared tickers |
|---|---|
| Rohit Khanna | 3 · AAPL, TSLA, GSK |
| Thomas H Tuberville | 3 · AAPL, TSLA, GSK |
| Thomas R Carper | 3 · AAPL, TSLA, GSK |
| Kurt Schrader | 3 · AAPL, TSLA, GSK |
| Marjorie Taylor Mrs Greene | 3 · AAPL, TSLA, GSK |
| Roger W. Marshall | 3 · AAPL, TSLA, GSK |
| James B. Renacci | 2 · AAPL, GSK |
| Josh Gottheimer | 2 · AAPL, TSLA |
| Sheldon Whitehouse | 2 · AAPL, TSLA |
| John Boozman | 2 · AAPL, GSK |
| Pat Roberts | 2 · AAPL, TSLA |
| Gilbert Cisneros | 2 · AAPL, TSLA |